Article Commentary: Alzheimer's Disease, Diagnosis and the Need for Biomarkers
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of aging that presents with memory loss, disorientation, confusion and a reduction in cognitive ability. Although a definite diagnosis of the disorder can only be made post-mortem by histopathological analysis, a number of met...
Main Authors: | Claudie Hooper, Simon Lovestone, Ricardo Sainz-Fuertes |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.4137/BMI.S682 |
Similar Items
-
Wnt3a induces exosome secretion from primary cultured rat microglia
by: Hooper Claudie, et al.
Published: (2012-11-01) -
Correction to: Wnt3a induces exosome secretion from primary cultured rat microglia
by: Claudie Hooper, et al.
Published: (2020-03-01) -
Blood based proteomic biomarkers of Alzheimer’s disease pathology
by: Alison Louise Baird, et al.
Published: (2015-11-01) -
Blood-based proteomic biomarkers of Alzheimer’s disease pathology
by: Baird, A, et al.
Published: (2015) -
p63α and γ Induce TAU Phosphorylation in Cultured Mammalian Cells
by: Claudie Hooper, et al.
Published: (2010-01-01)